SCHEMBL1957705

SCHEMBL1957705

CN1CCN(Nc2ccc([S+]([O-])NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)OC5)CC4)cc3Oc3cc4cc[nH]c4cc3F)cc2[N+](=O)[O-])CC1

nearest known ligand 0.82

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 17/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1957421 0.90 BCL2 (1.00) BCL2
SCHEMBL1959519 0.88 BCL2 (0.82) BCL2
SCHEMBL1959158 0.87 BCL2 (0.84) BCL2
SCHEMBL1959548 0.83 BCL2 (0.82) BCL2
SCHEMBL1957867 0.82 BCL2 (0.83) BCL2
SCHEMBL1957523 0.82 BCL2 (0.83) BCL2
SCHEMBL1957660 0.82 BCL2 (1.00) BCL2
SCHEMBL1958776 0.82 BCL2 (0.83) BCL2
SCHEMBL1956073 0.81 BCL2 (0.82) BCL2
SCHEMBL1958793 0.81 BCL2 (0.66) BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2507211-A1 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES Abbott Laboratories (US) 2012-10-10 — — EP disclosed
WO-2011068560-A1 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES ABBOTT LABORATORIES (US) 2011-06-09 — — WO disclosed
Send feedback